Sponsored by Digital Look Events

ValiRx(VAL)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE AIM All-Share

Market Cap

£3.14m

Change Today

0.000p

Share Price

6.75p

ValiRx Overview

ValiRx is in the pharmaceuticals & biotechnology sector and is currently trading at 6.75p per share. In the last year ValiRx's share price has ranged from 6.50p to 29.25p.

1 Day Chart (16-May-2008)

1 Day Chart

6 Month Chart

6 Month Chart

Income & Efficiency

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -275.4% n/a
ROCE -0.4%  

Valuation

Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 32.8 n/a
Pr/Book 1.2  

Growth

Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ValiRx Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-02 a0.02 a(2.84) (6,990.00)p n/a n/a n/a n/a 0.0%
31-Dec-03 an/a a(0.15) (124.20)p n/a n/a n/a n/a 0.0%
31-Dec-04 an/a a(0.34) (25.80)p n/a n/a n/a n/a 0.0%
31-Dec-05 n/a n/a (2.70)p n/a n/a n/a n/a 0.0%
31-Dec-06 0.10 n/a (3.30)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ValiRx Company Announcements

Holding(s) in Company 15-May-2008 12:37 RNS
Statement re Placing of Shares 12-May-2008 16:42 PR Newswire
Issue of Equity 08-May-2008 08:05 RNS

ValiRx ShareCast News

ValiRx granted Aussie patent for GeneICE 29-Jan-2008 ShareCast
Successful test results for ValiRx cancer drug 17-Jan-2008 ShareCast
ValiRx surges on joint venture news 11-Dec-2007 ShareCast

ValiRx Top Newspaper Links

Business Digest 24-Sep-2006 Sunday Times
Scandal-hit investors seek to win back losses 20-Aug-2005 Telegraph
Friday rush for Room Service 03-Dec-2003 Guardian

Latest ValiRx Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

ValiRx Market Data

Currency UK Pounds
Share Price 6.75p  
Change Today 0.000p
52 Week High 29.25p
52 Week Low 6.50p
Volume 0
Shares Issued 46.50m
Market Cap £3.14m
Beta 0.47
RiskGrade 313

ValiRx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.86% above the market average8.86% above the market average8.86% above the market average8.86% above the market average8.86% above the market average
34.12% above the sector average34.12% above the sector average34.12% above the sector average34.12% above the sector average34.12% above the sector average
Price Trend
74.15% below the market average74.15% below the market average74.15% below the market average74.15% below the market average74.15% below the market average
47.25% below the sector average47.25% below the sector average47.25% below the sector average47.25% below the sector average47.25% below the sector average
Income Not Available
Growth Not Available

ValiRx Dividends

No dividends found

Trades for --2008

Time Volume / Share Price
0 @ 0.000p